DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Shimon Sp. et al.
Ribociclib as first-line therapy for Hr-positive, advanced breast cancer.
N Eng J Med 2017;
376: 288-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.